Search research articles
Contact Us
Filters
Showing results (21-30 of 333) with videos related to
Page
of 34
Sort By:
European Journal of Gastroenterology & Hepatology
|
December 5, 2009
A case of compensated liver cirrhosis with hepatitis C virus of genotype 1b and high viral load in whom sustained virological response was achieved by 2-year administration of very low-dose recombinant interferon alpha-2b
Hideaki Kato, Makoto Nakamura, Atsushi Nakamura, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
|
August 22, 2002
[Clinical significance of soluble interleukin-2 receptor as a putative systemic nutritional index in the elderly]
Motoo Kikuchi, Toshiaki Inagaki, Nagao Shinagawa, et al.
Japanese Journal of Cancer Research : Gann
|
May 3, 2002
Lack of Ku80 alteration in multiple myeloma
Miyuki Kato, Shinsuke Iida, Hirokazu Komatsu, et al.
Hepatology (Baltimore, Md.)
|
December 19, 2013
Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab-containing chemotherapy
Shigeru Kusumoto, Yasuhito Tanaka, Masashi Mizokami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2010
Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy
Shigeru Kusumoto, Yasuhito Tanaka, Masashi Mizokami, et al.
International Journal of Hematology
|
June 23, 2009
Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma
Shigeru Kusumoto, Yasuhito Tanaka, Masashi Mizokami, et al.
Journal of Gastroenterology
|
October 7, 2010
Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy
Shigeru Kusumoto, Yasuhito Tanaka, Ryuzo Ueda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2013
Is antiviral prophylaxis necessary to prevent hepatitis B virus (HBV) reactivation in patients with HBV-resolved infection receiving rituximab-containing chemotherapy?
Shigeru Kusumoto, Yasuhito Tanaka, Masashi Mizokami, et al.
Current Alzheimer Research
|
June 25, 2005
Cognitive event-related potentials: useful clinical information in Alzheimer's disease
Eiichi Katada, Koichi Sato, Kosei Ojika, et al.
Japanese Journal of Clinical Oncology
|
January 29, 2016
Current status of immunotherapy
Susumu Suzuki, Takashi Ishida, Kazuhiro Yoshikawa, et al.
Page
of 34
Search research articles
Search
Showing results (21-30 of 333) with videos related to
Sort By:
Page
of 34
European Journal of Gastroenterology & Hepatology
|
December 5, 2009
A case of compensated liver cirrhosis with hepatitis C virus of genotype 1b and high viral load in whom sustained virological response was achieved by 2-year administration of very low-dose recombinant interferon alpha-2b
Hideaki Kato, Makoto Nakamura, Atsushi Nakamura, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
|
August 22, 2002
[Clinical significance of soluble interleukin-2 receptor as a putative systemic nutritional index in the elderly]
Motoo Kikuchi, Toshiaki Inagaki, Nagao Shinagawa, et al.
Japanese Journal of Cancer Research : Gann
|
May 3, 2002
Lack of Ku80 alteration in multiple myeloma
Miyuki Kato, Shinsuke Iida, Hirokazu Komatsu, et al.
Hepatology (Baltimore, Md.)
|
December 19, 2013
Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab-containing chemotherapy
Shigeru Kusumoto, Yasuhito Tanaka, Masashi Mizokami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2010
Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy
Shigeru Kusumoto, Yasuhito Tanaka, Masashi Mizokami, et al.
International Journal of Hematology
|
June 23, 2009
Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma
Shigeru Kusumoto, Yasuhito Tanaka, Masashi Mizokami, et al.
Journal of Gastroenterology
|
October 7, 2010
Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy
Shigeru Kusumoto, Yasuhito Tanaka, Ryuzo Ueda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2013
Is antiviral prophylaxis necessary to prevent hepatitis B virus (HBV) reactivation in patients with HBV-resolved infection receiving rituximab-containing chemotherapy?
Shigeru Kusumoto, Yasuhito Tanaka, Masashi Mizokami, et al.
Current Alzheimer Research
|
June 25, 2005
Cognitive event-related potentials: useful clinical information in Alzheimer's disease
Eiichi Katada, Koichi Sato, Kosei Ojika, et al.
Japanese Journal of Clinical Oncology
|
January 29, 2016
Current status of immunotherapy
Susumu Suzuki, Takashi Ishida, Kazuhiro Yoshikawa, et al.
Page
of 34